315 related articles for article (PubMed ID: 24667498)
1. JMJD6 promotes colon carcinogenesis through negative regulation of p53 by hydroxylation.
Wang F; He L; Huangyang P; Liang J; Si W; Yan R; Han X; Liu S; Gui B; Li W; Miao D; Jing C; Liu Z; Pei F; Sun L; Shang Y
PLoS Biol; 2014 Mar; 12(3):e1001819. PubMed ID: 24667498
[TBL] [Abstract][Full Text] [Related]
2. Livin promotes colon cancer progression by regulation of H2A.X
Ge Y; Liu BL; Cui JP; Li SQ
Life Sci; 2019 Oct; 234():116788. PubMed ID: 31445935
[TBL] [Abstract][Full Text] [Related]
3. JMJD6 promotes melanoma carcinogenesis through regulation of the alternative splicing of PAK1, a key MAPK signaling component.
Liu X; Si W; Liu X; He L; Ren J; Yang Z; Yang J; Li W; Liu S; Pei F; Yang X; Sun L
Mol Cancer; 2017 Nov; 16(1):175. PubMed ID: 29187213
[TBL] [Abstract][Full Text] [Related]
4. Lysyl 5-hydroxylation, a novel histone modification, by Jumonji domain containing 6 (JMJD6).
Unoki M; Masuda A; Dohmae N; Arita K; Yoshimatsu M; Iwai Y; Fukui Y; Ueda K; Hamamoto R; Shirakawa M; Sasaki H; Nakamura Y
J Biol Chem; 2013 Mar; 288(9):6053-62. PubMed ID: 23303181
[TBL] [Abstract][Full Text] [Related]
5. Biochemical and structural investigations clarify the substrate selectivity of the 2-oxoglutarate oxygenase JMJD6.
Islam MS; McDonough MA; Chowdhury R; Gault J; Khan A; Pires E; Schofield CJ
J Biol Chem; 2019 Jul; 294(30):11637-11652. PubMed ID: 31147442
[TBL] [Abstract][Full Text] [Related]
6. The hydroxylation activity of Jmjd6 is required for its homo-oligomerization.
Han G; Li J; Wang Y; Li X; Mao H; Liu Y; Chen CD
J Cell Biochem; 2012 May; 113(5):1663-70. PubMed ID: 22189873
[TBL] [Abstract][Full Text] [Related]
7. JMJD6 promotes hepatocellular carcinoma carcinogenesis by targeting CDK4.
Wan J; Liu H; Yang L; Ma L; Liu J; Ming L
Int J Cancer; 2019 May; 144(10):2489-2500. PubMed ID: 30125344
[TBL] [Abstract][Full Text] [Related]
8. Jumonji domain-containing protein 6 protein and its role in cancer.
Yang J; Chen S; Yang Y; Ma X; Shao B; Yang S; Wei Y; Wei X
Cell Prolif; 2020 Feb; 53(2):e12747. PubMed ID: 31961032
[TBL] [Abstract][Full Text] [Related]
9. Jumonji Domain Containing Protein 6: A Novel Oxygen Sensor in the Human Placenta.
Alahari S; Post M; Caniggia I
Endocrinology; 2015 Aug; 156(8):3012-25. PubMed ID: 26037477
[TBL] [Abstract][Full Text] [Related]
10. The epigenetic modifier JMJD6 is amplified in mammary tumors and cooperates with c-Myc to enhance cellular transformation, tumor progression, and metastasis.
Aprelikova O; Chen K; El Touny LH; Brignatz-Guittard C; Han J; Qiu T; Yang HH; Lee MP; Zhu M; Green JE
Clin Epigenetics; 2016; 8():38. PubMed ID: 27081402
[TBL] [Abstract][Full Text] [Related]
11. Role of the Epigenetic Modifier JMJD6 in Tumor Development and Regulation of Immune Response.
Wang K; Yang C; Li H; Liu X; Zheng M; Xuan Z; Mei Z; Wang H
Front Immunol; 2022; 13():859893. PubMed ID: 35359945
[TBL] [Abstract][Full Text] [Related]
12. Widespread hydroxylation of unstructured lysine-rich protein domains by JMJD6.
Cockman ME; Sugimoto Y; Pegg HB; Masson N; Salah E; Tumber A; Flynn HR; Kirkpatrick JM; Schofield CJ; Ratcliffe PJ
Proc Natl Acad Sci U S A; 2022 Aug; 119(32):e2201483119. PubMed ID: 35930668
[TBL] [Abstract][Full Text] [Related]
13. JMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancer.
Lee YF; Miller LD; Chan XB; Black MA; Pang B; Ong CW; Salto-Tellez M; Liu ET; Desai KV
Breast Cancer Res; 2012 May; 14(3):R85. PubMed ID: 22621393
[TBL] [Abstract][Full Text] [Related]
14. JMJD6 is a tumorigenic factor and therapeutic target in neuroblastoma.
Wong M; Sun Y; Xi Z; Milazzo G; Poulos RC; Bartenhagen C; Bell JL; Mayoh C; Ho N; Tee AE; Chen X; Li Y; Ciaccio R; Liu PY; Jiang CC; Lan Q; Jayatilleke N; Cheung BB; Haber M; Norris MD; Zhang XD; Marshall GM; Wang JY; Hüttelmaier S; Fischer M; Wong JWH; Xu H; Perini G; Dong Q; George RE; Liu T
Nat Commun; 2019 Jul; 10(1):3319. PubMed ID: 31346162
[TBL] [Abstract][Full Text] [Related]
15. MiR-770 inhibits tumorigenesis and EMT by targeting JMJD6 and regulating WNT/β-catenin pathway in non-small cell lung cancer.
Zhang Z; Yang Y; Zhang X
Life Sci; 2017 Nov; 188():163-171. PubMed ID: 28882645
[TBL] [Abstract][Full Text] [Related]
16. JMJD6 and U2AF65 co-regulate alternative splicing in both JMJD6 enzymatic activity dependent and independent manner.
Yi J; Shen HF; Qiu JS; Huang MF; Zhang WJ; Ding JC; Zhu XY; Zhou Y; Fu XD; Liu W
Nucleic Acids Res; 2017 Apr; 45(6):3503-3518. PubMed ID: 27899633
[TBL] [Abstract][Full Text] [Related]
17. Insights into Jumonji C-domain containing protein 6 (JMJD6): a multifactorial role in foot-and-mouth disease virus replication in cells.
Lawrence P; Rieder E
Virus Genes; 2017 Jun; 53(3):340-351. PubMed ID: 28364140
[TBL] [Abstract][Full Text] [Related]
18. Bifunctional Enzyme JMJD6 Contributes to Multiple Disease Pathogenesis: New Twist on the Old Story.
Vangimalla SS; Ganesan M; Kharbanda KK; Osna NA
Biomolecules; 2017 Jun; 7(2):. PubMed ID: 28587176
[TBL] [Abstract][Full Text] [Related]
19. The polyserine domain of the lysyl-5 hydroxylase Jmjd6 mediates subnuclear localization.
Wolf A; Mantri M; Heim A; Müller U; Fichter E; Mackeen MM; Schermelleh L; Dadie G; Leonhardt H; Vénien-Bryan C; Kessler BM; Schofield CJ; Böttger A
Biochem J; 2013 Aug; 453(3):357-70. PubMed ID: 23688307
[TBL] [Abstract][Full Text] [Related]
20. The JMJD2A demethylase regulates apoptosis and proliferation in colon cancer cells.
Kim TD; Shin S; Berry WL; Oh S; Janknecht R
J Cell Biochem; 2012 Apr; 113(4):1368-76. PubMed ID: 22134899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
